Welcome to the official documentation for LBtope, an advanced computational tool designed to predict linear (continuous) B-cell epitopes from an antigen's primary sequence. Identifying these epitopes is a cornerstone of peptide-based vaccine design and the development of diagnostic kits. LBtope improves upon previous methods by utilizing larger, experimentally validated datasets and robust machine-learning architectures.
Web Server: http://crdd.osdd.net/raghava/lbtope/(https://webs.iiitd.edu.in/raghava/lbtope)
Singh, H., Ansari, H. R., & Raghava, G. P. S. (2013). Improved Method for Linear B-Cell Epitope Prediction Using Antigen's Primary Sequence. PLOS ONE, 8(5), e62216. https://doi.org/10.1371/journal.pone.0062216
zonedo:-(https://doi.org/10.5281/zenodo.20097564)
B-cell epitopes are specific regions of an antigen that are recognized by B-lymphocytes. While epitopes can be conformational or linear, linear epitopes are particularly useful because they can be identified directly from the primary protein sequence. LBtope was developed using the most extensive datasets available from the Immune Epitope Database (IEDB) to ensure reliability and accuracy.
The method was trained and validated on three distinct types of datasets:
- Lbtope_Variable: 14,876 epitopes and 23,321 non-epitopes of varying lengths.
- Lbtope_Fixed: 12,063 epitopes and 20,589 non-epitopes of fixed length (20-mers).
- Lbtope_Confirm: 1,042 epitopes and 1,795 non-epitopes validated by at least two different experimental techniques or by multiple labs.
- Multiple Models: Offers various prediction modules based on Support Vector Machines (SVM) and various sequence features.
- Redundancy Reduced: Performance was rigorously tested on datasets where highly identical peptides were removed to prevent over-fitting.
- High Performance: Achieved an accuracy of approximately 81% on the Lbtope_Confirm dataset, significantly outperforming previous methods like ABCpred and BCPred.
- Antigen Scanning: Users can submit an entire protein sequence to identify potential B-cell epitopes.
- Epitope Evaluation: Specific peptide sequences can be submitted to check their probability of being an epitope.
- Adjustable Thresholds: Allows users to vary the threshold to balance sensitivity and specificity according to their experimental needs.
LBtope utilizes sophisticated feature extraction techniques to capture the essence of what makes a peptide sequence antigenic.
- Machine Learning: Developed using SVM-light with various kernels to find the optimal hyperplane for classification.
- Input Features: Includes amino acid composition, dipeptide composition, and binary profile patterns.
- Evolutionary Profiles: Incorporates PSSM (Position-Specific Scoring Matrix) profiles generated by PSI-BLAST for enhanced prediction.
- Vaccine Discovery: Identifying immunodominant regions in viral, bacterial, or parasite antigens.
- Antibody Production: Designing synthetic peptides to generate high-affinity antibodies.
- Immunological Research: Understanding the sequence-level properties that define B-cell recognition.
Prof. Gajendra P. S. Raghava Bioinformatics Centre, CSIR-Institute of Microbial Technology, Chandigarh, India. Email: raghava@imtech.res.in
This resource is open-access and distributed under the terms of the Creative Commons Attribution License, permitting unrestricted use and distribution provided the original work is properly credited.